Interactions of phage P22 tails with their cellular receptor, Salmonella O-antigen polysaccharide.

PubWeight™: 1.26‹?› | Rank: Top 10%

🔗 View Article (PMC 1233670)

Published in Biophys J on October 01, 1996

Authors

U Baxa1, S Steinbacher, S Miller, A Weintraub, R Huber, R Seckler

Author Affiliations

1: Universtät Regensburg, Institut für Biophysik und Physikalische Biochemie, Germany.

Articles citing this

Identification of the lipopolysaccharide core of Yersinia pestis and Yersinia pseudotuberculosis as the receptor for bacteriophage φA1122. J Bacteriol (2011) 1.66

Biocontrol of Escherichia coli O157 with O157-specific bacteriophages. Appl Environ Microbiol (1999) 1.55

Structure of the receptor-binding protein of bacteriophage det7: a podoviral tail spike in a myovirus. J Virol (2007) 1.32

Peering down the barrel of a bacteriophage portal: the genome packaging and release valve in p22. Structure (2011) 1.28

Characterization and comparative genomic analysis of a novel bacteriophage, SFP10, simultaneously inhibiting both Salmonella enterica and Escherichia coli O157:H7. Appl Environ Microbiol (2011) 1.11

The interdigitated beta-helix domain of the P22 tailspike protein acts as a molecular clamp in trimer stabilization. Protein Sci (2002) 0.97

Shared catalysis in virus entry and bacterial cell wall depolymerization. J Mol Biol (2009) 0.96

Orally administered P22 phage tailspike protein reduces salmonella colonization in chickens: prospects of a novel therapy against bacterial infections. PLoS One (2010) 0.95

Tailspike interactions with lipopolysaccharide effect DNA ejection from phage P22 particles in vitro. J Biol Chem (2010) 0.94

Role for cysteine residues in the in vivo folding and assembly of the phage P22 tailspike. Protein Sci (2001) 0.93

Thin pilus PilV adhesins of plasmid R64 recognize specific structures of the lipopolysaccharide molecules of recipient cells. J Bacteriol (2003) 0.92

Crystal structure of the passenger domain of the Escherichia coli autotransporter EspP. J Mol Biol (2011) 0.92

Multifunctional roles of a bacteriophage phi 29 morphogenetic factor in assembly and infection. J Mol Biol (2008) 0.90

Phage P22 tailspike protein: removal of head-binding domain unmasks effects of folding mutations on native-state thermal stability. Protein Sci (1998) 0.90

OmpA and OmpC are critical host factors for bacteriophage Sf6 entry in Shigella. Mol Microbiol (2014) 0.89

Buried hydrophobic side-chains essential for the folding of the parallel beta-helix domains of the P22 tailspike. Protein Sci (2004) 0.86

Natural solution to antibiotic resistance: bacteriophages 'The Living Drugs'. World J Microbiol Biotechnol (2014) 0.85

Recognition of Salmonella Typhimurium by Immobilized Phage P22 Monolayers. Surf Sci (2008) 0.85

Bacteriophages and phage-derived proteins--application approaches. Curr Med Chem (2015) 0.83

Complete genome sequence of Salmonella enterica serovar Typhimurium bacteriophage SPN3UB. J Virol (2012) 0.82

A BTP1 prophage gene present in invasive non-typhoidal Salmonella determines composition and length of the O-antigen of the lipopolysaccharide. Mol Microbiol (2015) 0.81

A Plant-Produced Bacteriophage Tailspike Protein for the Control of Salmonella. Front Plant Sci (2016) 0.79

Interaction of a Salmonella enteritidis O-antigen octasaccharide with the phage P22 tailspike protein by NMR spectroscopy and docking studies. Glycoconj J (2007) 0.78

Genomic investigation of lysogen formation and host lysis systems of the Salmonella temperate bacteriophage SPN9CC. Appl Environ Microbiol (2013) 0.78

Surface-immobilization of chromatographically purified bacteriophages for the optimized capture of bacteria. Bacteriophage (2012) 0.77

Protein folding failure sets high-temperature limit on growth of phage P22 in Salmonella enterica serovar Typhimurium. Appl Environ Microbiol (2004) 0.75

A Flagellar Glycan-Specific Protein Encoded by Campylobacter Phages Inhibits Host Cell Growth. Viruses (2015) 0.75

Bacteriophage tailspike protein based assay to monitor phase variable glucosylations in Salmonella O-antigens. BMC Microbiol (2016) 0.75

Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process. Appl Microbiol Biotechnol (2017) 0.75

Articles cited by this

Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol (1987) 66.52

Coupling of local folding to site-specific binding of proteins to DNA. Science (1994) 9.49

Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J Virol (1995) 3.82

in vitro MORPHOGENESIS OF PHAGE P22 FROM HEADS AND BASE-PLATE PARTS. Proc Natl Acad Sci U S A (1967) 2.93

Crystal structure of P22 tailspike protein: interdigitated subunits in a thermostable trimer. Science (1994) 2.41

Trimeric intermediate in the in vivo folding and subunit assembly of the tail spike endorhamnosidase of bacteriophage P22. Proc Natl Acad Sci U S A (1982) 1.49

The recognition event between virus and host cell receptor: a target for antiviral agents. J Gen Virol (1990) 1.47

Hemagglutinin-neuraminidase of human parainfluenza 3: role of the neuraminidase in the viral life cycle. Virology (1995) 1.37

Equilibrium and kinetic inhibition assays based upon fluorescence polarization. Methods Enzymol (1981) 1.36

Structure and functions of the bacteriophage P22 tail protein. J Virol (1980) 1.25

In vitro folding pathway of phage P22 tailspike protein. Biochemistry (1991) 1.23

Enzymic and molecular properties of base-plate parts of bacteriophage P22. Eur J Biochem (1976) 1.20

Approaches to labeling and identification of active site residues in glycosidases. Protein Sci (1995) 1.20

Reconstitution of the thermostable trimeric phage P22 tailspike protein from denatured chains in vitro. J Biol Chem (1989) 1.15

Salmonella phage glycanases: substrate specificity of the phage P22 endo-rhamnosidase. J Gen Virol (1979) 1.12

Thermodynamics of oligosaccharide binding to a monoclonal antibody specific for a Salmonella O-antigen point to hydrophobic interactions in the binding site. J Biol Chem (1992) 1.12

Folding and assembly of phage P22 tailspike endorhamnosidase lacking the N-terminal, head-binding domain. Eur J Biochem (1993) 1.07

Salmonella bacteriophage glycanases: endorhamnosidases of Salmonella typhimurium bacteriophages. J Virol (1979) 1.06

A model for the adsorption of phage P22 to Salmonella typhimurium. J Gen Virol (1978) 1.01

Characterization of bacteriophage P22 tailspike mutant proteins with altered endorhamnosidase and capsid assembly activities. J Biol Chem (1989) 0.92

Numerical integration of rate equations by computer: an update. Trends Biochem Sci (1994) 0.92

Effects of receptor destruction by Salmonella bacteriophages epsilon 15 and c341. Virology (1980) 0.91

A new fluorescent tag for labeling of saccharides. Anal Biochem (1983) 0.89

A synthetic sialic acid analogue is recognized by influenza C virus as a receptor determinant but is resistant to the receptor-destroying enzyme. J Biol Chem (1992) 0.84

Deacetylation reaction catalyzed by Salmonella phage c341 and its baseplate parts. J Biol Chem (1976) 0.82

New fluorogenic substrates for subtilisin. Chem Pharm Bull (Tokyo) (1985) 0.82

Thermodynamics of oligosaccharides binding to a dextran-specific monoclonal IgM. Mol Immunol (1988) 0.80

Articles by these authors

Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. Science (1995) 12.94

Structure of 20S proteasome from yeast at 2.4 A resolution. Nature (1997) 12.73

The origin of mutants. Nature (1988) 8.92

X-ray structure analysis of a membrane protein complex. Electron density map at 3 A resolution and a model of the chromophores of the photosynthetic reaction center from Rhodopseudomonas viridis. J Mol Biol (1984) 8.85

The complete genome of the hyperthermophilic bacterium Aquifex aeolicus. Nature (1998) 7.77

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study. Lancet (2004) 6.27

A gated channel into the proteasome core particle. Nat Struct Biol (2000) 5.42

Structure of the protein subunits in the photosynthetic reaction centre of Rhodopseudomonas viridis at 3Å resolution. Nature (2012) 5.22

Surface, subunit interfaces and interior of oligomeric proteins. J Mol Biol (1988) 4.80

Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet (1996) 4.62

The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J (1989) 4.49

Fourier Domain Mode Locking (FDML): A new laser operating regime and applications for optical coherence tomography. Opt Express (2006) 4.49

The structures of HsIU and the ATP-dependent protease HsIU-HsIV. Nature (2000) 4.46

Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA (2001) 4.26

Structure of bovine pancreatic trypsin inhibitor. Results of joint neutron and X-ray refinement of crystal form II. J Mol Biol (1984) 4.14

The time course of minimal excitory post-synaptic potentials evoked in spinal motoneurones by group Ia afferent fibres. J Physiol (1971) 3.93

Excitation of the corticospinal tract by electromagnetic and electrical stimulation of the scalp in the macaque monkey. J Physiol (1990) 3.66

Proteasome from Thermoplasma acidophilum: a threonine protease. Science (1995) 3.62

Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol (1984) 3.60

The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature (2000) 3.53

Crystallographic refinement and atomic models of two different forms of citrate synthase at 2.7 and 1.7 A resolution. J Mol Biol (1982) 3.28

Natural protein proteinase inhibitors and their interaction with proteinases. Eur J Biochem (1992) 3.27

Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J Mol Biol (2003) 3.25

Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 A and 1.0 A resolution. J Mol Biol (1980) 3.25

Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol (1996) 3.20

Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution. J Mol Biol (1974) 3.17

The proteasome. Annu Rev Biophys Biomol Struct (1999) 3.13

Crystallographic structure studies of an IgG molecule and an Fc fragment. Nature (1976) 3.00

East pacific rise: hot springs and geophysical experiments. Science (1980) 2.94

Crystal structure of the thermosome, the archaeal chaperonin and homolog of CCT. Cell (1998) 2.94

Structure of the tetrameric restriction endonuclease NgoMIV in complex with cleaved DNA. Nat Struct Biol (2000) 2.82

Crystal structure of a carbon monoxide dehydrogenase reveals a [Ni-4Fe-5S] cluster. Science (2001) 2.78

The accessible surface area and stability of oligomeric proteins. Nature (1987) 2.77

Enteropathogens in adult patients with diarrhea and healthy control subjects: a 1-year prospective study in a Swedish clinic for infectious diseases. Clin Infect Dis (2000) 2.77

The structure of a complex of recombinant hirudin and human alpha-thrombin. Science (1990) 2.71

Structure and mechanism of the aberrant ba(3)-cytochrome c oxidase from thermus thermophilus. EMBO J (2000) 2.71

The gap between patient reading comprehension and the readability of patient education materials. J Fam Pract (1990) 2.68

Structure determination and refinement of human alpha class glutathione transferase A1-1, and a comparison with the Mu and Pi class enzymes. J Mol Biol (1993) 2.66

Postexposure prophylaxis after nonoccupational HIV exposure: clinical, ethical, and policy considerations. JAMA (1998) 2.58

Phosphotransferase and substrate binding mechanism of the cAMP-dependent protein kinase catalytic subunit from porcine heart as deduced from the 2.0 A structure of the complex with Mn2+ adenylyl imidodiphosphate and inhibitor peptide PKI(5-24). EMBO J (1993) 2.54

Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization. Biochemistry (1986) 2.52

Amplified, frequency swept lasers for frequency domain reflectometry and OCT imaging: design and scaling principles. Opt Express (2005) 2.48

The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J (1988) 2.48

Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst (1995) 2.45

The refined 2.4 A X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. EMBO J (1990) 2.44

High-level biosynthetic substitution of methionine in proteins by its analogs 2-aminohexanoic acid, selenomethionine, telluromethionine and ethionine in Escherichia coli. Eur J Biochem (1995) 2.44

X-ray crystallographic structure of the light-harvesting biliprotein C-phycocyanin from the thermophilic cyanobacterium Mastigocladus laminosus and its resemblance to globin structures. J Mol Biol (1985) 2.42

Crystal structure of P22 tailspike protein: interdigitated subunits in a thermostable trimer. Science (1994) 2.41

The blue oxidases, ascorbate oxidase, laccase and ceruloplasmin. Modelling and structural relationships. Eur J Biochem (1990) 2.37

Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol (1997) 2.37

X-ray crystal structures of cytosolic glutathione S-transferases. Implications for protein architecture, substrate recognition and catalytic function. Eur J Biochem (1994) 2.37

The three-dimensional structure of class pi glutathione S-transferase in complex with glutathione sulfonate at 2.3 A resolution. EMBO J (1991) 2.36

Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology (2001) 2.36

Neurobiological basis of speech: a case for the preeminence of temporal processing. Ann N Y Acad Sci (1993) 2.35

Evidence of activity-dependent withdrawal of corticospinal projections during human development. Neurology (2001) 2.32

A gender-specific HIV/STD risk reduction intervention for women in a health care setting: short- and long-term results of a randomized clinical trial. AIDS Care (2002) 2.28

Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5.5 and pH 9.0. A pH-induced conformational transition involves a peptide bond flip. J Mol Biol (1991) 2.19

Crystal structure of a thermostable type B DNA polymerase from Thermococcus gorgonarius. Proc Natl Acad Sci U S A (1999) 2.19

Refined crystal structure of ascorbate oxidase at 1.9 A resolution. J Mol Biol (1992) 2.18

Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature (1997) 2.17

Structural homology of reaction centers from Rhodopseudomonas sphaeroides and Rhodopseudomonas viridis as determined by x-ray diffraction. Proc Natl Acad Sci U S A (1986) 2.16

Structural basis for the activation of human procaspase-7. Proc Natl Acad Sci U S A (2001) 2.14

Pyrobaculum aerophilum sp. nov., a novel nitrate-reducing hyperthermophilic archaeum. Appl Environ Microbiol (1993) 2.13

Structure of human des(1-45) factor Xa at 2.2 A resolution. J Mol Biol (1993) 2.07

A simple genetic basis for a complex psychological trait in laboratory mice. Science (1995) 2.06

Refined structure of the hirudin-thrombin complex. J Mol Biol (1991) 2.06

Refined three-dimensional structures of two cyanobacterial C-phycocyanins at 2.1 and 2.5 A resolution. A common principle of phycobilin-protein interaction. J Mol Biol (1987) 2.06

Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature (2000) 2.04

HIV/AIDS and maternity care in Kenya: how fears of stigma and discrimination affect uptake and provision of labor and delivery services. AIDS Care (2008) 2.04

The breast radiation injury litigation and the clinical oncologist. Clin Oncol (R Coll Radiol) (1998) 2.03

Crystal structure of a DNA-dependent RNA polymerase (DNA primase). Nat Struct Biol (2001) 2.03

Structure of astacin and implications for activation of astacins and zinc-ligation of collagenases. Nature (1992) 2.02

Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J Virol (1995) 2.01

The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity. EMBO J (1991) 1.99

Structural and functional aspects of domain motions in proteins. CRC Crit Rev Biochem (1984) 1.99

Unexpected complexity in the haplotypes of commonly used inbred strains of laboratory mice. Proc Natl Acad Sci U S A (2004) 1.99

The molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI refined at 2.0-A resolution. Biochemistry (1975) 1.98

Cognitive functioning and brain magnetic resonance imaging in children with sickle Cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics (1996) 1.98

Macrosomia--maternal characteristics and infant complications. Obstet Gynecol (1985) 1.96

The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. The refined crystal structures of the bovine trypsinogen-pancreatic trypsin inhibitor complex and of its ternary complex with Ile-Val at 1.9 A resolution. J Mol Biol (1978) 1.95

Lesions of the posterior paraventricular thalamus block habituation of hypothalamic-pituitary-adrenal responses to repeated restraint. J Neuroendocrinol (2002) 1.91

X-ray crystal structure of the blue oxidase ascorbate oxidase from zucchini. Analysis of the polypeptide fold and a model of the copper sites and ligands. J Mol Biol (1989) 1.90

Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr (1996) 1.90

Three-dimensional structure of the complex between pancreatic secretory trypsin inhibitor (Kazal type) and trypsinogen at 1.8 A resolution. Structure solution, crystallographic refinement and preliminary structural interpretation. J Mol Biol (1982) 1.90

The ternary microplasmin-staphylokinase-microplasmin complex is a proteinase-cofactor-substrate complex in action. Nat Struct Biol (1998) 1.85

Mistletoe therapy in oncology. Cochrane Database Syst Rev (2008) 1.84

Relationship between atmospheric temperature and survival of airborne bacteria. Appl Microbiol (1970) 1.84

Bovine chymotrypsinogen A X-ray crystal structure analysis and refinement of a new crystal form at 1.8 A resolution. J Mol Biol (1985) 1.81

Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc Natl Acad Sci U S A (1997) 1.80

Detection of a noble gas molecular ion, 36ArH+, in the Crab Nebula. Science (2013) 1.80

Crystal structure of gingipain R: an Arg-specific bacterial cysteine proteinase with a caspase-like fold. EMBO J (1999) 1.79

Crystal structure of bovine trypsinogen at 1-8 A resolution. II. Crystallographic refinement, refined crystal structure and comparison with bovine trypsin. J Mol Biol (1977) 1.79

Mutational studies on HslU and its docking mode with HslV. Proc Natl Acad Sci U S A (2000) 1.79

Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. EMBO J (1998) 1.79

Sequence statistics reliably predict stabilizing mutations in a protein domain. J Mol Biol (1994) 1.77

Comparison of two highly refined structures of bovine pancreatic trypsin inhibitor. J Mol Biol (1987) 1.77

Crystal and molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI. Eur J Biochem (1974) 1.76